[
  {
    "ts": "2026-01-30T05:24:16+00:00",
    "headline": "Truist Highlights Nuvation Bio’s (NUVB) Ibtrozi’s Robust Market Uptake and Lead Over Competitors",
    "summary": "Nuvation Bio Inc. (NYSE:NUVB) is one of the best high short interest stocks with biggest upside potential. On January 27, Truist raised its price target on Nuvation Bio to $13 from $11 and maintained a Buy rating, citing the Ibtrozi franchise’s robust initial performance as part of a Q4 2025 earnings preview for the biotech […]",
    "url": "https://finance.yahoo.com/news/truist-highlights-nuvation-bio-nuvb-052416025.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d5fbebce-6eda-373f-93db-d5ef4c23520d",
      "content": {
        "id": "d5fbebce-6eda-373f-93db-d5ef4c23520d",
        "contentType": "STORY",
        "title": "Truist Highlights Nuvation Bio’s (NUVB) Ibtrozi’s Robust Market Uptake and Lead Over Competitors",
        "description": "",
        "summary": "Nuvation Bio Inc. (NYSE:NUVB) is one of the best high short interest stocks with biggest upside potential. On January 27, Truist raised its price target on Nuvation Bio to $13 from $11 and maintained a Buy rating, citing the Ibtrozi franchise’s robust initial performance as part of a Q4 2025 earnings preview for the biotech […]",
        "pubDate": "2026-01-30T05:24:16Z",
        "displayTime": "2026-01-30T05:24:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/0342e7650e054600fee008f2a522e39b",
          "originalWidth": 4032,
          "originalHeight": 3024,
          "caption": "Truist Highlights Nuvation Bio's (NUVB) Ibtrozi’s Robust Market Uptake and Lead Over Competitors",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RsAn6HBEnyelJNe991n6Pg--~B/aD0zMDI0O3c9NDAzMjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/0342e7650e054600fee008f2a522e39b.cf.webp",
              "width": 4032,
              "height": 3024,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cdGttinL_Pb.3Kbmx6cnAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0342e7650e054600fee008f2a522e39b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-highlights-nuvation-bio-nuvb-052416025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-highlights-nuvation-bio-nuvb-052416025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NUVB"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]